EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

The Cost-Effectiveness and Budget Impact Analysis of Upadacitinib for Moderate-to-Severe Atopic Dermatitis in Saudi Arabia

Nada Abu-Shraie, Afaf Al-Sheikh, Ibtisam Alharbi, Layla Alanizy, Mohammed Alshraim, Sahal I Khoshhal, Sarah A AlSalman, Ali Alrumaih, Ahmad Nader Fasseeh, Baher Elezbawy, Nada Abaza, Amr Semida und 3 weitere

ClinicoEconomics and Outcomes Research · 2026-06 · Volume 18 · 1-14

DOI: 10.2147/ceor.s604093 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ClinicoEconomics and Outcomes Research, 2026-06. Verfasst von Nada Abu-Shraie und 14 weiteren Autor:innen. Beteiligte Einrichtung: Ministry of National Guard-Health Affairs (MNGHA), King Abdul Aziz Medical City (KAMC), Riyadh, Saudi Arabia. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Saudi Arabiaatopic dermatitisbudget impactcost-effectivenesseczemaupadacitinib

Autor:innen und Institutionen

  • Ministry of National Guard-Health Affairs (MNGHA), King Abdul Aziz Medical City (KAMC), Riyadh, Saudi Arabia.
  • Medical Services for Armed Forces, Ministry of Defence, Jeddah, Saudi Arabia.
  • Department of Clinical Pharmacy, King Saud University, Riyadh, Saudi Arabia.
  • Pharmaceutical Care Services, International Medical Center, Jeddah, Saudi Arabia.
  • Medical Services for Armed Forces, Ministry of Defence, Riyadh, Saudi Arabia.
  • Syreon Middle East, Alexandria, Egypt.

Zitieren

APA

Abu-Shraie, N., Al-Sheikh, A., Alharbi, I., Alanizy, L., Alshraim, M., Khoshhal, S. I., AlSalman, S. A., Alrumaih, A., Fasseeh, A. N., Elezbawy, B., Abaza, N., Semida, A., George, M., Amin, S., & Binamer, Y. (2026). The Cost-Effectiveness and Budget Impact Analysis of Upadacitinib for Moderate-to-Severe Atopic Dermatitis in Saudi Arabia. ClinicoEconomics and Outcomes Research, Volume 18, 1-14. https://doi.org/10.2147/ceor.s604093

Vancouver

Abu-Shraie N, Al-Sheikh A, Alharbi I, Alanizy L, Alshraim M, Khoshhal SI, et al. The Cost-Effectiveness and Budget Impact Analysis of Upadacitinib for Moderate-to-Severe Atopic Dermatitis in Saudi Arabia. ClinicoEconomics and Outcomes Research. 2026;Volume 18:1-14. doi:10.2147/ceor.s604093

BibTeX
@article{AbuShraie2026,
  author = {Abu-Shraie, Nada and Al-Sheikh, Afaf and Alharbi, Ibtisam and Alanizy, Layla and Alshraim, Mohammed and Khoshhal, Sahal I and AlSalman, Sarah A and Alrumaih, Ali and Fasseeh, Ahmad Nader and Elezbawy, Baher and Abaza, Nada and Semida, Amr and George, Marina and Amin, Shireen and Binamer, Yousef},
  title = {The Cost-Effectiveness and Budget Impact Analysis of Upadacitinib for Moderate-to-Severe Atopic Dermatitis in Saudi Arabia},
  journal = {ClinicoEconomics and Outcomes Research},
  year = {2026},
  volume = {Volume 18},
  pages = {1--14},
  doi = {10.2147/ceor.s604093}
}
Kostenlos starten →